Skip to main content

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.

36,950
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,732
Class I recallsReasonable probability of serious health consequences
24,263
Class II recallsTemporary or medically reversible health consequences
2,873
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,071 recalls
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,458 recalls have been announced year to date.
  • Aug 2026 was 53% lower than the previous complete period (Jul 2026: 240).
  • The highest complete period was Jun 2026 (297).
  • Sep 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,263
Class I9,732
Class III2,873
Not Yet Classified1
Download CSV
Recalls by class
ClassRecalls
Class II24,263
Class I9,732
Class III2,873
Not Yet Classified1

Showing 741–760 of 17,260 recalls

FDA Recall Ongoing Historical recordClass II

Duloxetine Delayed-Release Capsules, USP, 60 mg, 1000-Capsule bottles, Rx Only, Manufactured by: Towa Pharmaceuticals Europe, S.L. Marotrelles, (Barcelona), Spain, Manufactured for : Quallient Pharmaceuticals Health, LLC, Grand Cayman, Cayman Islands, NDC 82009-032-10.

by Breckenridge Pharmaceutical, Inc.

Reason
CGMP Deviations; presence of N-nitroso-duloxetine impurity above the FDA recommended limit
Published
December 10, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Wecare Calasoothe, Net wt. 4 oz (113 g), Manufactured for: Dynarex Corporation, 10 Glenshaw Street, Orangeburg, NY 10962, NDC 67777-234-04.

by Blossom Pharmaceuticals

Reason
cGMP deviations
Published
December 10, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Globe Zinc Oxide Ointment USP Zinc Oxide 20% Skin Protectant, Net Wt. 2 oz (56.7 g), Distributed by: Trifecta Pharmaceuticals USA 101 NE, Third Avenue, Suite 1500, Ft. Lauderdale, FL 33301, NDC 69396-086-02.

by Blossom Pharmaceuticals

Reason
cGMP deviations
Published
December 10, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Globe Clotrimazole Cream USP, 1 % Antifungal Cream, Net Wt., 5 oz. (142 g, Distributed by: Trifecta Pharmaceuticals USA, 101 NE Third Avenue, Suite 1500, Ft. Lauderdale, FL 33301, USA, NDC 69396-087-55.

by Blossom Pharmaceuticals

Reason
cGMP deviations
Published
December 10, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Globe Clotrimazole Cream, USP, 1 %, Net Wt. 1 oz (28.4g), Distributed by: Trifecta Pharmaceuticals USA, 101 NE Third Avenue, Suite 1500, Ft. Lauderdale, FL 33301 USA, Made in India, NDC 69396-087-01.

by Blossom Pharmaceuticals

Reason
cGMP deviations
Published
December 10, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Nivagen, Zinc Oxide Ointment USP, Zinc Oxide 20 %, Net Wt. 1 oz. (28.4g), Nivagen Pharmaceuticals, Inc., Sacramento, CA 95827, USA, Made in India, NDC 75834-170-02.

by Blossom Pharmaceuticals

Reason
cGMP deviations
Published
December 10, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Nivagen, Zinc Oxide Ointment, Net Wt. 1 oz. (28.4g), Nivagen Pharmaceuticals, Inc., Sacramento, CA 95827, USA Made in India, NDC 75834-170-01.

by Blossom Pharmaceuticals

Reason
cGMP deviations
Published
December 10, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Dynashield, 4 oz cream (113 g), Manufactured for: Dynarex Corporation, 10 Glenshaw Street, Orangeburg, NY 10852, USA, Made in India, NDC 67777-407-03.

by Blossom Pharmaceuticals

Reason
cGMP deviations
Published
December 10, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Nivagen Pharmaceuticals, Zinc Oxide Ointment USP, Zinc Oxide 20% Skin Protectant, Net Wt. 15 oz (425g), Made in India, Manufactured for: Nivagen Pharmaceuticals, Inc., Sacramento, CA 95827, USA, NDC 75834-170-15.

by Blossom Pharmaceuticals

Reason
cGMP deviations
Published
December 10, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

WeCare, Zinc Oxide Ointment, Net Wt. 15 oz/425 g, Manuactured for: Dynarex Corporation, 11 Dynarex Drive, Middletown, NY 10941, Made in India, NDC 67777-223-05.

by Blossom Pharmaceuticals

Reason
cGMP deviations
Published
December 10, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Dynagel, Moisturizing Wound Hydrogel, Net Wt. 3oz (84.7 g), Manufactured for: Dynarex Corporation, 16 Glenshaw Street, Orangeburg, NY 10962, UPC 61784128016.

by Blossom Pharmaceuticals

Reason
cGMP deviations
Published
December 10, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Wecare Enema, 4.5 Fl Oz/133mL, Manufactured for: Dynarex Corporation, 11 Dynarex Corporation, MIddletown, NY 10941 USA, Made in India, NDC 67777-402-01.

by Blossom Pharmaceuticals

Reason
cGMP deviations
Published
December 10, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Dynashield Skin Protectant, Net Wt. 16 oz (453.6 g), Manufactured for: Dyrnarex Corporation, 10 Glenshaw Street, Orangeburg, NY 10962, USA, Made in India, NDC 67777-407-04.

by Blossom Pharmaceuticals

Reason
cGMP deviations
Published
December 10, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Lanashield Skin Barrier, 4 oz. (113 g), Manfuactured for: Dynarex Corporation, 10 Gleshaw Street, Orangeburg, NY 10962 USA, Made in India, UPC 616784126319.

by Blossom Pharmaceuticals

Reason
cGMP deviations
Published
December 10, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass III

Bisoprolol Fumarate and Hydrochlorothiazide Tablets, USP, 2.5 mg/6.25 mg, packaged as (a) 30-count bottles, NDC-68462-878-30; (b) 100-count bottle, NDC-68462-878-01; (c) 500-count bottles, NDC-68462-878-05; Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, Inda. Manufactured for: Glenmark Pharmaceuticals, Inc., USA, Mahwah, NJ 07430.

by Glenmark Pharmaceuticals Inc., USA

Reason
Cross Contamination with Other Products: Testing of reserve samples showed presence of traces of ezetimibe
Published
December 10, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass III

Carton label: Testosterone Gel 1%, 2.5 grams per unit dose, CIII, 30 unit-dose packets, Rx only, Manufactured by: Actavis Laboratories, Inc, Salt Lake City, UT 84108, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, NDC 0591-3216-30. Packet label: Testosterone Gel 1%, contains 2.5 grams, For topical use only, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054,NDC: 0591-3216-17.

by Teva Pharmaceuticals USA, Inc

Reason
Defective Container - A defect in the side-seal which allows leakage of product.
Published
December 10, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Phytonadione Injectable Emulsion, USP 10mg/mL, 10x1 mL Single-Dose Vial/carton, Rx Only, Mfd. by: Cipla Ltd. India At M/s Immacule Lifesciences PVT. Ltd. India. Mfd. for: Cipla USA, Inc. Warren, NJ 07059. Vial NDC# 69097-708-31; Carton NDC 69097-708-96

by Cipla Limited

Reason
Failed Stability Specifications: Observed OOS results: eg results for colour index
Published
December 10, 2025
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass II

Water Pure, Inc.

Product
My Bladder; Supports normal bladder tone & control; Dietary…
Reason
Product may be contaminated with E. coli O7:K1 (IAI39/ExPEC) and E. coli 1303
Published
December 10, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass I

Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL vials, Rx only, Fresenius Kabi USA, LLC, NDC 63323-739-11 (unit of use), 63323-739-12 (unit of sale).

by Fresenius Kabi USA, LLC

Reason
Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing.
Published
December 3, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Walgreens Saline Nasal Spray WITH XYLITOL, 1.5 oz (45mL) bottle, DISTRIBUTED BY: WALGREEN CO., 200 WILMOT RD., DEERFIELD, IL 60015, NDC 0363-3114-01

by Medical Products Laboratories, Inc.

Reason
Microbial contamination of a non-sterile product - microorganism found to be pseudomonas lactis
Published
December 3, 2025
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.